StockNow
CalendarLog in
Global Markets

CHMP recommends EU approval of Novo's (NOVOB DC) FREHEMGO, the first factor VIIIa mimetic offering monthly, once-every-two-weeks and weekly dosing in a pre-filled pen for the treatment of haemophilia A

StockNow breaking-news AI analysis

CHMP recommended EU approval for Novo's FREHEMGO, the first factor VIIIa mimetic offering weekly, bi-weekly, and monthly dosing via pre-filled pen for haemophilia A.

1 stocks
NVONovo-Nordisk A/S$42.98Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

A high-ranking source told Al Mayadeen that Saudi Arabia has asked the Sultanate of Oman to request a two-week truce from the Houthis, during which discussions will be held to address the humanitarian situation

Geopolitics

Political adviser to Iran’s Supreme Leader says the Strait of Hormuz will not be reopened until US President Trump and Israeli PM Netanyahu are “brought down from the seat of power”, Tasnim reports

U.S. Markets

Nvidia (NVDA) CEO Huang says AI safety is paramount; Nvidia (NVDA) to sell twice as many chips next year as this year

NVDA